发明名称 |
Somatic stem cells |
摘要 |
A method of treating a cellular proliferative disorder in a subject by obtaining from a subject a bodily fluid sample containing a plurality of cells, incubating the sample with EDTA or heparin in a container until the sample is separated into an upper layer and a lower layer, collecting the upper layer, isolating from the upper layer a population of somatic stem cells that are 0.3-6.0 micrometers in size, differentiating the somatic stem cells to dendritic cells in a medium containing GCSF, SCF, EGF, PDGF, bFGF, and IL-3, purifying the dendritic cells, contacting the dendritic cells thus purified with a cancer antigen, and administrating an effective amount of the dendritic cells presenting the cancer antigen to a subject in need thereof. |
申请公布号 |
US8986679(B2) |
申请公布日期 |
2015.03.24 |
申请号 |
US201313895686 |
申请日期 |
2013.05.16 |
申请人 |
Stembios Technologies, Inc. |
发明人 |
Wang James |
分类号 |
A61K39/00;C12N5/071;C12N5/074;A61K35/28;C12N5/0784;G01N33/50;A61K35/14;A61K35/12 |
主分类号 |
A61K39/00 |
代理机构 |
Cesari and McKenna, LLP |
代理人 |
Cesari and McKenna, LLP |
主权项 |
1. A method of treating a cellular proliferative disorder in a subject, the method comprising:
obtaining a bodily fluid sample containing a plurality of cells, incubating the sample with EDTA or heparin in a container until the sample is separated into an upper layer and a lower layer, collecting the upper layer, isolating from the upper layer a population of somatic stem cells that are 0.3-6.0 micrometers in size and CD9+, differentiating the somatic stem cells to dendritic cells in a medium containing GCSF, SCF, EGF, PDGF, bFGF, and IL-3, the dendritic cells being CD83+ and CD86+, purifying the dendritic cells, contacting the dendritic cells thus purified with a cancer antigen, and administering an effective amount of the dendritic cells presenting the cancer antigen to a subject in need thereof. |
地址 |
Monterey Park CA US |